These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37323089)

  • 1. The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens.
    Pacini MF; Perdomini A; Bulfoni Balbi C; Dinatale B; Herrera FE; Perez AR; Marcipar I
    Proteins; 2023 Oct; 91(10):1444-1460. PubMed ID: 37323089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accessing the Variability of Multicopy Genes in Complex Genomes using Unassembled Next-Generation Sequencing Reads: The Case of Trypanosoma cruzi Multigene Families.
    Reis-Cunha JL; Coqueiro-Dos-Santos A; Pimenta-Carvalho SA; Marques LP; Rodrigues-Luiz GF; Baptista RP; Almeida LV; Honorato NRM; Lobo FP; Fraga VG; Galvão LMDC; Bueno LL; Fujiwara RT; Cardoso MS; Cerqueira GC; Bartholomeu DC
    mBio; 2022 Dec; 13(6):e0231922. PubMed ID: 36264102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diversity and expansion of the trans-sialidase gene family is a common feature in Trypanosoma cruzi clade members.
    Chiurillo MA; Cortez DR; Lima FM; Cortez C; Ramírez JL; Martins AG; Serrano MG; Teixeira MM; da Silveira JF
    Infect Genet Evol; 2016 Jan; 37():266-74. PubMed ID: 26640033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity.
    Freitas LM; dos Santos SL; Rodrigues-Luiz GF; Mendes TA; Rodrigues TS; Gazzinelli RT; Teixeira SM; Fujiwara RT; Bartholomeu DC
    PLoS One; 2011; 6(10):e25914. PubMed ID: 22039427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.
    Khatoon N; Ojha R; Mishra A; Prajapati VK
    Vaccine; 2018 Oct; 36(42):6290-6300. PubMed ID: 30217522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.
    Beucher M; Norris KA
    Infect Immun; 2008 Feb; 76(2):750-8. PubMed ID: 18070905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
    Burle-Caldas GA; Dos Santos NSA; de Castro JT; Mugge FLB; Grazielle-Silva V; Oliveira AER; Pereira MCA; Reis-Cunha JL; Dos Santos AC; Gomes DA; Bartholomeu DC; Moretti NS; Schenkman S; Gazzinelli RT; Teixeira SMR
    mBio; 2022 Feb; 13(1):e0347821. PubMed ID: 35073735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance.
    Tzelepis F; de Alencar BC; Penido ML; Claser C; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
    J Immunol; 2008 Feb; 180(3):1737-48. PubMed ID: 18209071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses.
    Bunkofske ME; Perumal N; White B; Strauch EM; Tarleton R
    J Immunol; 2023 Feb; 210(4):420-430. PubMed ID: 36603035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.
    Mendes TA; Reis Cunha JL; de Almeida Lourdes R; Rodrigues Luiz GF; Lemos LD; dos Santos AR; da Câmara AC; Galvão LM; Bern C; Gilman RH; Fujiwara RT; Gazzinelli RT; Bartholomeu DC
    PLoS Negl Trop Dis; 2013; 7(10):e2524. PubMed ID: 24205430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.
    Alvarez MG; Postan M; Weatherly DB; Albareda MC; Sidney J; Sette A; Olivera C; Armenti AH; Tarleton RL; Laucella SA
    PLoS Negl Trop Dis; 2008; 2(9):e288. PubMed ID: 18846233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
    Serna C; Lara JA; Rodrigues SP; Marques AF; Almeida IC; Maldonado RA
    Vaccine; 2014 Jun; 32(28):3525-32. PubMed ID: 24793944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
    Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
    Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.
    Pacini MF; González FB; Dinatale B; Bulfoni Balbi C; Villar SR; Farré C; Lupi G; Espariz M; Blancato VS; Magni C; Marcipar I; Pérez AR
    Vaccine; 2022 Apr; 40(15):2311-2323. PubMed ID: 35279330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.